A 26-year-old man undergoing surgical correction of his deviated septum experiences excessive bleeding on the operating room table. Preoperative prothrombin time and platelet count were normal. The patient’s past medical history is significant for frequent blue blemishes on his skin along with easy bruising since he was a child. He indicated that he has some sort of genetic blood disorder running in his family but could not recall any details. Which of the following is the most appropriate treatment for this patient’s most likely condition?
Q742
A 75-year-old woman is being treated for atrial fibrillation. She presents to the clinic with complaints of nausea, vomiting, photophobia, and yellow-green vision with yellow halos around the lights. She has a heart rate of 64/min, blood pressure is 118/76 mm Hg, and respiratory rate is 15/min. Physical examination reveals regular heart sounds with clear lung sounds bilaterally. Liver function tests are normal. Toxicity of which of the following anti-arrhythmic drugs would best fit this clinical picture?
Q743
A 20-year-old woman presents to the emergency department after developing a widespread rash when she was playing in the park. She states she feels somewhat light-headed. She is otherwise healthy and has no significant past medical history. Her temperature is 97.0°F (36.1°C), blood pressure is 84/54 mmHg, pulse is 130/min, respirations are 22/min, and oxygen saturation is 95% on room air. Physical exam is notable for bilateral wheezing and a diffuse urticarial rash. Which of the following is the next best step in management?
Q744
A 47-year-old woman presents to the emergency department in a frantic state and demands immediate treatment for an allergic reaction, which started soon after she had lunch (approximately 1 hour ago). She had her usual meal consisting of homemade salad and lemonade. She was recently started on niacin because she could not tolerate statins. The only other medication she takes is captopril for hypertension. She has no respiratory difficulty and denies rhinorrhea, epiphora, and diarrhea. She is complaining of a stinging sensation on her face. She has no history of allergies and no family history of allergies. The vital signs include: pulse 90/min, respirations 16/min, blood pressure 120/80 mm Hg, and oxygen saturation, 98% on room air. On physical examination, the face and trunk have a flushed appearance. The rest of the physical examination is unremarkable. The attending physician reassures her that she is not in any immediate danger, and in fact, her symptoms subsided over the next hour. She is advised to take aspirin 30 minutes before her other medications and sent home. Which of the following is the etiology of her symptoms?
Q745
A 64-year-old woman presents to the emergency department with a 1-hour history of shortness of breath and chest pain. She said that the symptoms came on suddenly and that the chest pain is worse when she tries to take a deep breath. Her past medical history is significant for a previous deep venous thrombosis for which she was taking a blood thinner. She also has diabetes, hypertension, hyperlipidemia, and partial seizures which are treated with metformin, lisinopril, atorvastatin, and carbamazepine and valproic acid, respectively. Which of these drugs is most likely responsible for causing this patient's blood thinner medications to fail?
Q746
A 72-year-old man with a 4-year history of Parkinson disease comes to the physician for evaluation of his medication. Since his last visit one year ago, he has had increased tremor and bradykinesia up to an hour before his next scheduled dose and sometimes feels like he does not respond to some doses at all. One week ago, he was entirely unable to move for about a minute when he wanted to exit an elevator. The physician prescribes a drug that increases the bioavailability of levodopa by preferentially preventing its peripheral methylation. This patient was most likely prescribed which of the following drugs by the physician?
Q747
A 77-year-old man with type 2 diabetes mellitus is admitted to the hospital because of chest pain and dyspnea. Serum troponin levels are elevated and an ECG shows ST-segment depressions in the lateral leads. Percutaneous coronary angiography is performed and occlusion of the distal left anterior descending coronary artery is identified. Pharmacotherapy with eptifibatide is initiated and a drug-eluting stent is placed in the left anterior descending coronary artery. The mechanism by which eptifibatide acts is similar to the underlying pathophysiology of which of the following conditions?
Q748
An 18-year-old man presents to his primary care provider for a routine checkup. He feels well and has no complaints. He is the captain of his high school football team and will be attending college on a football scholarship the following year. His past medical history is unremarkable. He underwent a laparoscopic appendectomy at age 13. He takes no medications and has no allergies. His temperature is 99.1°F (37.3°C), blood pressure is 155/85 mmHg, pulse is 96/min, and respirations are 16/min. On examination, he has severe nodulocystic acne. He has gained 15 pounds and 1/2 inch in height since his last visit one year ago. Mild gynecomastia and testicular shrinkage are noted. This patient is at the greatest risk of developing which of the following?
Q749
A 60-year-old male presents to your office for follow-up after an upper gastrointestinal (GI) endoscopy revealed the presence of esophageal varices. His medical history is significant for cirrhosis caused by heavy alcohol abuse for the past 20 years. He was instructed to follow-up with his primary care physician for management of his condition. Which of the following is the most appropriate next step for prevention of future variceal bleeding?
Q750
A 36-year-old woman is admitted to the hospital because of irritability, nausea, and diarrhea. She has a history of recreational oxycodone use and last took a dose 48 hours ago. Physical examination shows mydriasis, rhinorrhea, and piloerection. A drug is administered that provides an effect similar to oxycodone but does not cause euphoria. Which of the following best explains the difference in effect?
Autonomic/CV Drugs US Medical PG Practice Questions and MCQs
Question 741: A 26-year-old man undergoing surgical correction of his deviated septum experiences excessive bleeding on the operating room table. Preoperative prothrombin time and platelet count were normal. The patient’s past medical history is significant for frequent blue blemishes on his skin along with easy bruising since he was a child. He indicated that he has some sort of genetic blood disorder running in his family but could not recall any details. Which of the following is the most appropriate treatment for this patient’s most likely condition?
A. Cryoprecipitate
B. Fresh frozen plasma
C. Red blood cell transfusion
D. Recombinant factor IX
E. Desmopressin and tranexamic acid (Correct Answer)
Explanation: **Desmopressin and tranexamic acid**
* The patient's clinical presentation, including excessive bleeding during surgery and a history of easy bruising and blue blemishes since childhood, are highly suggestive of **Von Willebrand Disease (VWD)**.
* **Desmopressin (DDAVP)** is the primary treatment for type 1 VWD, as it promotes the release of endogenous **von Willebrand factor (VWF)** and **factor VIII** from endothelial cells. **Tranexamic acid** is an antifibrinolytic agent that helps stabilize clots and reduce bleeding.
*Cryoprecipitate*
* While cryoprecipitate contains vWF, factor VIII, and fibrinogen, it is a **blood product** and carries the risks associated with transfusion. It is typically reserved for **severe types of VWD** or when desmopressin is ineffective or contraindicated.
* The initial management of VWD, especially for bleeding episodes or surgical prophylaxis, usually starts with desmopressin, given its efficacy and lower risk profile.
*Fresh frozen plasma*
* **Fresh frozen plasma (FFP)** contains all clotting factors but at lower concentrations than cryoprecipitate for vWF. It is primarily used for **multiple factor deficiencies** or **warfarin reversal**.
* Its primary role in VWD management is limited, as direct vWF replacement or stimulation is preferred for this condition.
*Red blood cell transfusion*
* **Red blood cell (RBC) transfusion** is indicated for patients with **significant blood loss** leading to anemia, but it does not address the underlying clotting defect in VWD.
* While this patient is experiencing excessive bleeding, an RBC transfusion would only treat the symptom of blood loss, not the cause.
*Recombinant factor IX*
* **Recombinant factor IX** is used to treat **hemophilia B**, which is a deficiency in factor IX.
* The patient's symptoms are inconsistent with hemophilia B; his normal platelet count and PTT (implicitly, since PT is normal and PTT is often affected in severe VWD or hemophilia) point away from hemophilia and towards a primary hemostasis defect like VWD.
Question 742: A 75-year-old woman is being treated for atrial fibrillation. She presents to the clinic with complaints of nausea, vomiting, photophobia, and yellow-green vision with yellow halos around the lights. She has a heart rate of 64/min, blood pressure is 118/76 mm Hg, and respiratory rate is 15/min. Physical examination reveals regular heart sounds with clear lung sounds bilaterally. Liver function tests are normal. Toxicity of which of the following anti-arrhythmic drugs would best fit this clinical picture?
A. Sotalol
B. Propafenone
C. Digoxin (Correct Answer)
D. Atenolol
E. Amiodarone
Explanation: ***Digoxin***
- **Digoxin toxicity** is classically associated with **pathognomonic visual disturbances** like yellow-green vision (xanthopsia) and halo effects, along with gastrointestinal symptoms such as nausea and vomiting.
- The patient's presentation of a **slow heart rate (bradycardia)** and treatment for atrial fibrillation further supports digoxin as the likely cause, given its use in rate control and its known narrow therapeutic index.
- The combination of xanthopsia, GI symptoms, and bradycardia makes digoxin toxicity the clear diagnosis.
*Sotalol*
- This is a **beta-blocker** with potassium channel blocking properties (Class III), commonly used for atrial fibrillation.
- Its adverse effects include **bradycardia**, dizziness, fatigue, and potential for **Torsades de Pointes** (QT prolongation), but not the specific visual or gastrointestinal symptoms seen here.
*Propafenone*
- Propafenone is a **Class IC antiarrhythmic** agent that can cause side effects like dizziness, metallic taste, and gastrointestinal upset.
- However, it does not typically cause the specific visual changes (yellow-green vision, halos) associated with the presented case.
*Atenolol*
- Atenolol is a **beta-1 selective beta-blocker** primarily used for rate control in atrial fibrillation and hypertension.
- Common side effects include **bradycardia**, fatigue, and dizziness, but it does not cause yellow-green vision or halos.
*Amiodarone*
- Amiodarone is a **Class III antiarrhythmic** with a wide range of side effects, including pulmonary fibrosis, thyroid dysfunction, and corneal deposits (which can cause halos around lights).
- While it can cause halos, it does not typically lead to the specific yellow-green vision (xanthopsia) described, and corneal deposits develop gradually with chronic use, not acutely as in this case.
Question 743: A 20-year-old woman presents to the emergency department after developing a widespread rash when she was playing in the park. She states she feels somewhat light-headed. She is otherwise healthy and has no significant past medical history. Her temperature is 97.0°F (36.1°C), blood pressure is 84/54 mmHg, pulse is 130/min, respirations are 22/min, and oxygen saturation is 95% on room air. Physical exam is notable for bilateral wheezing and a diffuse urticarial rash. Which of the following is the next best step in management?
A. Normal saline
B. Continuous monitoring
C. Diphenhydramine
D. Albuterol
E. Epinephrine (Correct Answer)
Explanation: ***Epinephrine***
- The patient presents with classic signs of **anaphylaxis**, including a widespread urticarial rash, wheezing, hypotension, and lightheadedness. **Epinephrine** is the first-line treatment for anaphylaxis due to its alpha-1 agonist effects (increasing blood pressure and reducing angioedema) and beta-2 agonist effects (bronchodilation).
- Delaying administration of **epinephrine** can lead to rapid progression of symptoms and potentially fatal outcomes.
*Normal saline*
- While **intravenous fluids** like normal saline may be indicated later to help manage hypotension in anaphylaxis, they are not the immediate priority.
- **Epinephrine** addresses the underlying pathophysiological processes of anaphylaxis more directly and quickly than fluid resuscitation alone.
*Continuous monitoring*
- While continuous monitoring is always important in unstable patients, it is not an intervention.
- The patient's vital signs and clinical presentation require immediate therapeutic intervention, not just observation.
*Diphenhydramine*
- **Diphenhydramine**, an H1 antihistamine, can help alleviate cutaneous symptoms like urticaria and pruritus.
- However, it does not address the life-threatening aspects of anaphylaxis, such as hypotension, bronchospasm, or upper airway edema, and should only be used as an adjunct to epinephrine.
*Albuterol*
- **Albuterol** is a beta-2 adrenergic agonist that can help with bronchospasm and wheezing.
- While it may be a useful adjunct, it does not address the cardiovascular collapse (hypotension) or the generalized systemic reaction of anaphylaxis, making epinephrine the more comprehensive and life-saving initial treatment.
Question 744: A 47-year-old woman presents to the emergency department in a frantic state and demands immediate treatment for an allergic reaction, which started soon after she had lunch (approximately 1 hour ago). She had her usual meal consisting of homemade salad and lemonade. She was recently started on niacin because she could not tolerate statins. The only other medication she takes is captopril for hypertension. She has no respiratory difficulty and denies rhinorrhea, epiphora, and diarrhea. She is complaining of a stinging sensation on her face. She has no history of allergies and no family history of allergies. The vital signs include: pulse 90/min, respirations 16/min, blood pressure 120/80 mm Hg, and oxygen saturation, 98% on room air. On physical examination, the face and trunk have a flushed appearance. The rest of the physical examination is unremarkable. The attending physician reassures her that she is not in any immediate danger, and in fact, her symptoms subsided over the next hour. She is advised to take aspirin 30 minutes before her other medications and sent home. Which of the following is the etiology of her symptoms?
A. Drug overdose
B. A mild allergic reaction
C. Serotonin
D. Anxiety
E. Prostaglandin release (Correct Answer)
Explanation: ***Prostaglandin release***
- The patient's symptoms of **flushing**, **stinging** sensation, and **non-allergic** reaction occurring after starting **niacin** are highly characteristic of a **prostaglandin-mediated response**. Niacin (Vitamin B3) often causes flushing due to its effect on prostaglandin D2 (PGD2) release from mast cells and keratinocytes.
- The recommendation to take **aspirin** 30 minutes before niacin specifically targets this mechanism, as aspirin inhibits **cyclooxygenase (COX) enzymes**, thereby reducing prostaglandin synthesis and mitigating the flushing.
*Drug overdose*
- The patient's vital signs are stable, and the clinical presentation, including isolated flushing and stinging that resolves spontaneously, does not align with typical symptoms of a **drug overdose**. An overdose would likely present with more severe and systemic effects.
- The symptoms are directly attributable to the **therapeutic use of niacin**, not an excessive dose, as they are a known side effect at standard dosages.
*A mild allergic reaction*
- The patient denies typical allergic symptoms like **rhinorrhea**, **epiphora** (watery eyes), **respiratory difficulty**, or **diarrhea**, and there is no history or family history of allergies. Her symptoms are specifically limited to flushing and stinging.
- The clinical course, especially the spontaneous resolution and the effectiveness of aspirin in prevention, points away from an **IgE-mediated allergic reaction**.
*Serotonin*
- While serotonin can cause flushing, it is typically associated with **carcinoid syndrome**, which presents with additional symptoms such as **diarrhea**, **wheezing**, and **tachycardia**, often in the context of neuroendocrine tumors.
- The patient's stable vital signs and lack of other systemic symptoms, as well as the clear temporal relationship with niacin, make **serotonin release** an unlikely primary etiology.
*Anxiety*
- While anxiety can precipitate some physical symptoms, the acute onset of **flushing** and **stinging** in a defined pattern, immediately following a meal and shortly after starting a known flushing-inducing medication (**niacin**), is less consistent with a primary anxiety attack.
- Her anxiety appears to be secondary to the physical symptoms she is experiencing, rather than the underlying cause of the **flushing** and **stinging**.
Question 745: A 64-year-old woman presents to the emergency department with a 1-hour history of shortness of breath and chest pain. She said that the symptoms came on suddenly and that the chest pain is worse when she tries to take a deep breath. Her past medical history is significant for a previous deep venous thrombosis for which she was taking a blood thinner. She also has diabetes, hypertension, hyperlipidemia, and partial seizures which are treated with metformin, lisinopril, atorvastatin, and carbamazepine and valproic acid, respectively. Which of these drugs is most likely responsible for causing this patient's blood thinner medications to fail?
A. Valproic acid
B. Lisinopril
C. Carbamazepine (Correct Answer)
D. Atorvastatin
E. Metformin
Explanation: ***Carbamazepine***
- **Carbamazepine** is a potent **CYP450 enzyme inducer**, which means it can increase the metabolism of other drugs, including many **warfarin-type anticoagulants**.
- By accelerating the breakdown of the blood thinner, carbamazepine can effectively reduce its concentration in the blood, leading to a **subtherapeutic anticoagulant effect** and an increased risk of **thrombosis**.
*Valproic acid*
- Valproic acid is generally considered a **CYP450 enzyme inhibitor**, meaning it would typically increase the concentration of co-administered drugs rather than decrease them.
- While it can have complex drug interactions, its primary effect on anticoagulants would usually be to **potentiate their effects**, increasing bleeding risk, not reducing efficacy.
*Lisinopril*
- **Lisinopril** is an **ACE inhibitor** and does not significantly interact with the cytochrome P450 enzyme system responsible for metabolizing most anticoagulants.
- It is unlikely to cause a failure of blood thinner medications through pharmacokinetic interactions.
*Atorvastatin*
- **Atorvastatin** is primarily metabolized by CYP3A4, and while it can have some minor drug interactions, it is not a potent inducer of the metabolizing enzymes for common anticoagulants.
- It does not significantly alter the efficacy of blood thinners like warfarin to the extent that it would cause treatment failure.
*Metformin*
- **Metformin** is primarily excreted unchanged by the kidneys and does not undergo significant hepatic metabolism via the CYP450 system.
- Therefore, it has minimal drug interactions with anticoagulants and would not be expected to cause their failure.
Question 746: A 72-year-old man with a 4-year history of Parkinson disease comes to the physician for evaluation of his medication. Since his last visit one year ago, he has had increased tremor and bradykinesia up to an hour before his next scheduled dose and sometimes feels like he does not respond to some doses at all. One week ago, he was entirely unable to move for about a minute when he wanted to exit an elevator. The physician prescribes a drug that increases the bioavailability of levodopa by preferentially preventing its peripheral methylation. This patient was most likely prescribed which of the following drugs by the physician?
A. Carbidopa
B. Amantadine
C. Entacapone (Correct Answer)
D. Rasagiline
E. Ropinirole
Explanation: ***Entacapone***
- Entacapone is a **catechol-O-methyltransferase (COMT) inhibitor** that acts peripherally, preventing the methylation of levodopa to 3-O-methyldopa.
- By reducing peripheral breakdown, entacapone **increases the bioavailability and half-life of levodopa**, which is useful for managing "wearing-off" phenomena and "on-off" fluctuations present in this patient.
*Carbidopa*
- Carbidopa is a **dopa decarboxylase inhibitor** that prevents the peripheral conversion of levodopa to dopamine, reducing systemic side effects and increasing levodopa's entry into the brain.
- While essential for levodopa therapy, it does not act by preventing levodopa's methylation and aims to prevent its decarboxylation, not methylation.
*Amantadine*
- Amantadine is an **antiviral drug** that also has dopaminergic properties, used primarily to treat **dyskinesias** associated with long-term levodopa therapy in Parkinson disease.
- It does not directly affect the metabolism or bioavailability of levodopa through methylation pathways.
*Rasagiline*
- Rasagiline is a **monoamine oxidase-B (MAO-B) inhibitor** that selectively blocks the breakdown of dopamine in the brain, thereby increasing dopamine levels.
- It helps to reduce "off" time but does not primarily work by affecting the peripheral methylation of levodopa.
*Ropinirole*
- Ropinirole is a **dopamine agonist** that directly stimulates dopamine receptors in the brain, acting as a substitute for dopamine.
- It is used to manage Parkinson symptoms but does not modulate levodopa's metabolism or bioavailability.
Question 747: A 77-year-old man with type 2 diabetes mellitus is admitted to the hospital because of chest pain and dyspnea. Serum troponin levels are elevated and an ECG shows ST-segment depressions in the lateral leads. Percutaneous coronary angiography is performed and occlusion of the distal left anterior descending coronary artery is identified. Pharmacotherapy with eptifibatide is initiated and a drug-eluting stent is placed in the left anterior descending coronary artery. The mechanism by which eptifibatide acts is similar to the underlying pathophysiology of which of the following conditions?
A. Von Willebrand disease
B. Glanzmann thrombasthenia (Correct Answer)
C. Vitamin K deficiency
D. Protein C deficiency
E. Thrombotic thrombocytopenic purpura
Explanation: ***Glanzmann thrombasthenia***
- Eptifibatide is a **glycoprotein IIb/IIIa receptor inhibitor**, preventing platelet aggregation by blocking the binding of **fibrinogen** to activated platelets.
- **Glanzmann thrombasthenia** is an inherited disorder characterized by a quantitative or qualitative defect in the **glycoprotein IIb/IIIa receptor**, leading to impaired platelet aggregation despite normal platelet count.
*Von Willebrand disease*
- This condition involves a deficiency or defect in **von Willebrand factor**, which is crucial for **platelet adhesion** to the subendothelium and as a carrier protein for factor VIII.
- Eptifibatide directly targets **platelet aggregation**, not platelet adhesion or von Willebrand factor function.
*Vitamin K deficiency*
- Vitamin K is essential for the synthesis of **coagulation factors II, VII, IX, and X**, as well as proteins C and S.
- A deficiency in vitamin K primarily affects the **coagulation cascade** and not platelet function directly.
*Protein C deficiency*
- **Protein C** is a natural anticoagulant that inactivates factors Va and VIIIa, thus regulating coagulation.
- A deficiency leads to a **hypercoagulable state** by impairing the anticoagulant pathway, which is distinct from platelet aggregation inhibition.
*Thrombotic thrombocytopenic purpura*
- This is a microangiopathic hemolytic anemia caused by a deficiency of **ADAMTS13**, an enzyme that cleaves large von Willebrand factor multimers, leading to abnormal platelet aggregation and thrombi formation.
- While it involves platelet aggregation, the mechanism is due to a defect in ADAMTS13 and vWF, not a direct issue with the **IIb/IIIa receptor**.
Question 748: An 18-year-old man presents to his primary care provider for a routine checkup. He feels well and has no complaints. He is the captain of his high school football team and will be attending college on a football scholarship the following year. His past medical history is unremarkable. He underwent a laparoscopic appendectomy at age 13. He takes no medications and has no allergies. His temperature is 99.1°F (37.3°C), blood pressure is 155/85 mmHg, pulse is 96/min, and respirations are 16/min. On examination, he has severe nodulocystic acne. He has gained 15 pounds and 1/2 inch in height since his last visit one year ago. Mild gynecomastia and testicular shrinkage are noted. This patient is at the greatest risk of developing which of the following?
A. Type 1 diabetes mellitus
B. Renal cyst
C. Hepatocellular carcinoma
D. Testicular enlargement
E. Hepatic adenoma (Correct Answer)
Explanation: ***Hepatic adenoma***
- The patient's presentation with **severe nodulocystic acne**, **mild gynecomastia**, **testicular shrinkage**, and **hypertension** in an athletic young male strongly suggests anabolic steroid abuse.
- **Anabolic steroid use** is associated with an increased risk of developing **hepatic adenomas**, which are benign liver tumors that can rupture and cause life-threatening hemorrhage.
*Type 1 diabetes mellitus*
- This condition is an **autoimmune destruction of pancreatic beta cells**, typically presenting with polyuria, polydipsia, and weight loss.
- The patient's symptoms are not consistent with new-onset diabetes, and steroid use is more linked to insulin resistance (Type 2) rather than Type 1 diabetes.
*Renal cyst*
- **Renal cysts** are typically asymptomatic and discovered incidentally. While some genetic conditions can cause multiple cysts, there's no direct link between anabolic steroid use and the development of isolated renal cysts.
- The patient's symptoms do not point towards kidney pathology as the primary concern.
*Hepatocellular carcinoma*
- While prolonged and high-dose anabolic steroid use can increase the risk of certain liver complications, including a rare association with hepatocellular carcinoma, **hepatic adenoma** is a more common and acute risk in the context of steroid abuse, especially with the potential for rupture.
- The immediate and often life-threatening complication associated with anabolic steroid-induced liver changes is typically hepatic adenoma rupture.
*Testicular enlargement*
- Anabolic steroid use leads to **exogenous testosterone suppression of endogenous testosterone production**, resulting in **testicular atrophy** or shrinkage, not enlargement.
- The scenario explicitly mentions testicular shrinkage, which directly contradicts testicular enlargement.
Question 749: A 60-year-old male presents to your office for follow-up after an upper gastrointestinal (GI) endoscopy revealed the presence of esophageal varices. His medical history is significant for cirrhosis caused by heavy alcohol abuse for the past 20 years. He was instructed to follow-up with his primary care physician for management of his condition. Which of the following is the most appropriate next step for prevention of future variceal bleeding?
A. Octreotide
B. Nadolol (Correct Answer)
C. Transjugular intrahepatic portosystemic shunt
D. Isosorbide mononitrate
E. Careful observation
Explanation: ***Nadolol***
- **Nadolol** is a non-selective beta-blocker that reduces portal pressure by causing **splanchnic vasoconstriction** and decreasing cardiac output, thereby preventing initial variceal bleeding in patients with cirrhosis.
- Beta-blockers like nadolol are considered **first-line therapy** for the primary prevention of variceal bleeding in patients with esophageal varices.
*Octreotide*
- **Octreotide** is primarily used in the **acute management** of variceal bleeding to reduce splanchnic blood flow and portal pressure, not for long-term primary prevention.
- Its mechanism involves inhibiting vasodilator peptides, which differs from the sustained effects needed for prevention.
*Transjugular intrahepatic portosystemic shunt*
- **TIPS** is typically reserved for patients with **recurrent variceal bleeding** despite medical and endoscopic therapy, or intractable ascites, and is not a first-line primary prevention strategy due to its invasiveness and potential complications.
- It involves creating a shunt between the portal and hepatic veins to decompress the portal system, a more aggressive intervention.
*Isosorbide mononitrate*
- **Isosorbide mononitrate** is a **vasodilator** that can reduce portal pressure but has been shown to increase the risk of adverse events and **does not improve survival** in primary prophylaxis of variceal bleeding.
- Its use in this context is generally discouraged due to lack of efficacy and safety concerns compared to beta-blockers.
*Careful observation*
- Given the patient has known **esophageal varices** and a history of cirrhosis due to alcohol abuse, **careful observation** without intervention is not an appropriate strategy.
- There is a high risk of life-threatening variceal bleeding, necessitating active primary prevention.
Question 750: A 36-year-old woman is admitted to the hospital because of irritability, nausea, and diarrhea. She has a history of recreational oxycodone use and last took a dose 48 hours ago. Physical examination shows mydriasis, rhinorrhea, and piloerection. A drug is administered that provides an effect similar to oxycodone but does not cause euphoria. Which of the following best explains the difference in effect?
A. Lower efficacy (Correct Answer)
B. Lower bioavailability
C. Lower potency
D. Lower affinity
E. Lower tolerance
Explanation: ***Lower efficacy***
- The administered drug acts as a **partial opioid agonist**, meaning it produces an effect similar to oxycodone (an opioid agonist) but with a **lower maximal effect**, explaining the absence of euphoria.
- While it can suppress withdrawal symptoms, its **intrinsic activity** at the opioid receptor is less than that of a full agonist.
*Lower bioavailability*
- **Bioavailability** refers to the fraction of an administered dose that reaches the systemic circulation; it does not directly explain differences in **maximal effect** or the absence of euphoria.
- A drug with lower bioavailability would simply require a higher dose to achieve the desired effect, but its inherent efficacy would remain the same.
*Lower potency*
- **Potency** refers to the concentration or dose of a drug required to produce 50% of that drug's maximal effect, which is about the affinity of the drug to the receptor.
- A drug can be potent but still achieve a high maximal effect, which would cause euphoria.
*Lower affinity*
- **Affinity** describes how strongly a drug binds to its receptor; a drug with lower affinity would simply require higher concentrations to bind to the receptors, and it does not explain the absence of a maximal effect.
- **Affinity** is a determinant of potency but not of the **intrinsic activity** or maximal efficacy of the drug.
*Lower tolerance*
- **Tolerance** is a phenomenon where the body adapts to a drug, requiring higher doses over time to achieve the same effect; it is a patient-specific response, not a property of the drug itself.
- Tolerance develops over time with repeated exposure and does not explain why an initial drug administration lacks euphoria.
